Variant · Snv
VHL P40R (c.119C>G)
CI-VAR-00003342Explore in graph →NP_000542.1:p.Pro40ArgNM_000551.3:c.119C>GClinVar 809420 CIViC 2430 rs200343185
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 9523203
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Von Hippel-Lindau Disease1unmapped disease | ||||||||
| VHL P40R (c.119C>G) | (predisposing) | Predisposing | C | Supports Uncertain Significance | 2 | submitted | EID6500A case report revealed a 34-year-old, Caucasian male diagnosed with bilateral pheochromocytoma. Genetic testing revealed a c.500G>A (p.Arg167Gln) mutation in the VHL gene. The paper did not explicitly… (full text at CIViC) PMID 9523203 · Teh et al., 1998 · Open in CIViC | civic |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 809420 | Uncertain significance | criteria provided, multiple submitters, no conflicts | 2 | Chuvash polycythemia; Von Hippel-Lindau syndrome | germline | 3 | Feb 24, 2023 | clinvar |